img

Global Monoclonal Antibody ADC Drugs Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Monoclonal Antibody ADC Drugs Market Insights, Forecast to 2034

Monoclonal antibody ADC drug is a complex formed by linking cytotoxic drugs to tumor-targeting monoclonal antibodies, and a complex formed by linking cytotoxic drugs to tumor-targeting monoclonal antibodies.
Global Monoclonal Antibody ADC Drugs market is expected to reach to US$ 721.4 million in 2024, with a positive growth of %, compared with US$ 617.6 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Monoclonal Antibody ADC Drugs industry is evaluated to reach US$ 1831.6 million in 2029. The CAGR will be 16.8% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Monoclonal Antibody ADC Drugs market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Monoclonal Antibody ADC Drugs market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Seattle
Roche
Pfizer
AstraZeneca
Immunomedics
GSK
ADC Therapeutics
Lepu Biopharma
Shanghai Junshi Biosciences
RemeGen
Segment by Type
CD30 Target Antigen
HER2 Target Antigen
CD22 Target Antigen
CD33 Target Antigen
Nectin-4 Target Antigen
Others

Segment by Application


Lymphoma
Breast Cancer
Leukemia
Myeloma
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Monoclonal Antibody ADC Drugs plant distribution, commercial date of Monoclonal Antibody ADC Drugs, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Monoclonal Antibody ADC Drugs introduction, etc. Monoclonal Antibody ADC Drugs Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Monoclonal Antibody ADC Drugs
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Monoclonal Antibody ADC Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Monoclonal Antibody ADC Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 CD30 Target Antigen
1.2.3 HER2 Target Antigen
1.2.4 CD22 Target Antigen
1.2.5 CD33 Target Antigen
1.2.6 Nectin-4 Target Antigen
1.2.7 Others
1.3 Market by Application
1.3.1 Global Monoclonal Antibody ADC Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Lymphoma
1.3.3 Breast Cancer
1.3.4 Leukemia
1.3.5 Myeloma
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Monoclonal Antibody ADC Drugs Sales Estimates and Forecasts 2018-2029
2.2 Global Monoclonal Antibody ADC Drugs Revenue by Region
2.2.1 Global Monoclonal Antibody ADC Drugs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Monoclonal Antibody ADC Drugs Revenue by Region (2018-2024)
2.2.3 Global Monoclonal Antibody ADC Drugs Revenue by Region (2024-2029)
2.2.4 Global Monoclonal Antibody ADC Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Monoclonal Antibody ADC Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Monoclonal Antibody ADC Drugs Sales by Region
2.4.1 Global Monoclonal Antibody ADC Drugs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Monoclonal Antibody ADC Drugs Sales by Region (2018-2024)
2.4.3 Global Monoclonal Antibody ADC Drugs Sales by Region (2024-2029)
2.4.4 Global Monoclonal Antibody ADC Drugs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Monoclonal Antibody ADC Drugs Sales by Manufacturers
3.1.1 Global Monoclonal Antibody ADC Drugs Sales by Manufacturers (2018-2024)
3.1.2 Global Monoclonal Antibody ADC Drugs Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Monoclonal Antibody ADC Drugs in 2022
3.2 Global Monoclonal Antibody ADC Drugs Revenue by Manufacturers
3.2.1 Global Monoclonal Antibody ADC Drugs Revenue by Manufacturers (2018-2024)
3.2.2 Global Monoclonal Antibody ADC Drugs Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Monoclonal Antibody ADC Drugs Revenue in 2022
3.3 Global Key Players of Monoclonal Antibody ADC Drugs, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Monoclonal Antibody ADC Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Monoclonal Antibody ADC Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Monoclonal Antibody ADC Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Monoclonal Antibody ADC Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Monoclonal Antibody ADC Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Monoclonal Antibody ADC Drugs Sales by Type
4.1.1 Global Monoclonal Antibody ADC Drugs Historical Sales by Type (2018-2024)
4.1.2 Global Monoclonal Antibody ADC Drugs Forecasted Sales by Type (2024-2029)
4.1.3 Global Monoclonal Antibody ADC Drugs Sales Market Share by Type (2018-2029)
4.2 Global Monoclonal Antibody ADC Drugs Revenue by Type
4.2.1 Global Monoclonal Antibody ADC Drugs Historical Revenue by Type (2018-2024)
4.2.2 Global Monoclonal Antibody ADC Drugs Forecasted Revenue by Type (2024-2029)
4.2.3 Global Monoclonal Antibody ADC Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Monoclonal Antibody ADC Drugs Price by Type
4.3.1 Global Monoclonal Antibody ADC Drugs Price by Type (2018-2024)
4.3.2 Global Monoclonal Antibody ADC Drugs Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Monoclonal Antibody ADC Drugs Sales by Application
5.1.1 Global Monoclonal Antibody ADC Drugs Historical Sales by Application (2018-2024)
5.1.2 Global Monoclonal Antibody ADC Drugs Forecasted Sales by Application (2024-2029)
5.1.3 Global Monoclonal Antibody ADC Drugs Sales Market Share by Application (2018-2029)
5.2 Global Monoclonal Antibody ADC Drugs Revenue by Application
5.2.1 Global Monoclonal Antibody ADC Drugs Historical Revenue by Application (2018-2024)
5.2.2 Global Monoclonal Antibody ADC Drugs Forecasted Revenue by Application (2024-2029)
5.2.3 Global Monoclonal Antibody ADC Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Monoclonal Antibody ADC Drugs Price by Application
5.3.1 Global Monoclonal Antibody ADC Drugs Price by Application (2018-2024)
5.3.2 Global Monoclonal Antibody ADC Drugs Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Monoclonal Antibody ADC Drugs Market Size by Type
6.1.1 US & Canada Monoclonal Antibody ADC Drugs Sales by Type (2018-2029)
6.1.2 US & Canada Monoclonal Antibody ADC Drugs Revenue by Type (2018-2029)
6.2 US & Canada Monoclonal Antibody ADC Drugs Market Size by Application
6.2.1 US & Canada Monoclonal Antibody ADC Drugs Sales by Application (2018-2029)
6.2.2 US & Canada Monoclonal Antibody ADC Drugs Revenue by Application (2018-2029)
6.3 US & Canada Monoclonal Antibody ADC Drugs Market Size by Country
6.3.1 US & Canada Monoclonal Antibody ADC Drugs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Monoclonal Antibody ADC Drugs Sales by Country (2018-2029)
6.3.3 US & Canada Monoclonal Antibody ADC Drugs Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Monoclonal Antibody ADC Drugs Market Size by Type
7.1.1 Europe Monoclonal Antibody ADC Drugs Sales by Type (2018-2029)
7.1.2 Europe Monoclonal Antibody ADC Drugs Revenue by Type (2018-2029)
7.2 Europe Monoclonal Antibody ADC Drugs Market Size by Application
7.2.1 Europe Monoclonal Antibody ADC Drugs Sales by Application (2018-2029)
7.2.2 Europe Monoclonal Antibody ADC Drugs Revenue by Application (2018-2029)
7.3 Europe Monoclonal Antibody ADC Drugs Market Size by Country
7.3.1 Europe Monoclonal Antibody ADC Drugs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Monoclonal Antibody ADC Drugs Sales by Country (2018-2029)
7.3.3 Europe Monoclonal Antibody ADC Drugs Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Monoclonal Antibody ADC Drugs Market Size
8.1.1 China Monoclonal Antibody ADC Drugs Sales (2018-2029)
8.1.2 China Monoclonal Antibody ADC Drugs Revenue (2018-2029)
8.2 China Monoclonal Antibody ADC Drugs Market Size by Application
8.2.1 China Monoclonal Antibody ADC Drugs Sales by Application (2018-2029)
8.2.2 China Monoclonal Antibody ADC Drugs Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Monoclonal Antibody ADC Drugs Market Size by Type
9.1.1 Asia Monoclonal Antibody ADC Drugs Sales by Type (2018-2029)
9.1.2 Asia Monoclonal Antibody ADC Drugs Revenue by Type (2018-2029)
9.2 Asia Monoclonal Antibody ADC Drugs Market Size by Application
9.2.1 Asia Monoclonal Antibody ADC Drugs Sales by Application (2018-2029)
9.2.2 Asia Monoclonal Antibody ADC Drugs Revenue by Application (2018-2029)
9.3 Asia Monoclonal Antibody ADC Drugs Sales by Region
9.3.1 Asia Monoclonal Antibody ADC Drugs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Monoclonal Antibody ADC Drugs Revenue by Region (2018-2029)
9.3.3 Asia Monoclonal Antibody ADC Drugs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Seattle
11.1.1 Seattle Company Information
11.1.2 Seattle Overview
11.1.3 Seattle Monoclonal Antibody ADC Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Seattle Monoclonal Antibody ADC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Seattle Recent Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Overview
11.2.3 Roche Monoclonal Antibody ADC Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Roche Monoclonal Antibody ADC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Roche Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Overview
11.3.3 Pfizer Monoclonal Antibody ADC Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Pfizer Monoclonal Antibody ADC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer Recent Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Company Information
11.4.2 AstraZeneca Overview
11.4.3 AstraZeneca Monoclonal Antibody ADC Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 AstraZeneca Monoclonal Antibody ADC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 AstraZeneca Recent Developments
11.5 Immunomedics
11.5.1 Immunomedics Company Information
11.5.2 Immunomedics Overview
11.5.3 Immunomedics Monoclonal Antibody ADC Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Immunomedics Monoclonal Antibody ADC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Immunomedics Recent Developments
11.6 GSK
11.6.1 GSK Company Information
11.6.2 GSK Overview
11.6.3 GSK Monoclonal Antibody ADC Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 GSK Monoclonal Antibody ADC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GSK Recent Developments
11.7 ADC Therapeutics
11.7.1 ADC Therapeutics Company Information
11.7.2 ADC Therapeutics Overview
11.7.3 ADC Therapeutics Monoclonal Antibody ADC Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 ADC Therapeutics Monoclonal Antibody ADC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 ADC Therapeutics Recent Developments
11.8 Lepu Biopharma
11.8.1 Lepu Biopharma Company Information
11.8.2 Lepu Biopharma Overview
11.8.3 Lepu Biopharma Monoclonal Antibody ADC Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Lepu Biopharma Monoclonal Antibody ADC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Lepu Biopharma Recent Developments
11.9 Shanghai Junshi Biosciences
11.9.1 Shanghai Junshi Biosciences Company Information
11.9.2 Shanghai Junshi Biosciences Overview
11.9.3 Shanghai Junshi Biosciences Monoclonal Antibody ADC Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Shanghai Junshi Biosciences Monoclonal Antibody ADC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Shanghai Junshi Biosciences Recent Developments
11.10 RemeGen
11.10.1 RemeGen Company Information
11.10.2 RemeGen Overview
11.10.3 RemeGen Monoclonal Antibody ADC Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 RemeGen Monoclonal Antibody ADC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 RemeGen Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Monoclonal Antibody ADC Drugs Industry Chain Analysis
12.2 Monoclonal Antibody ADC Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Monoclonal Antibody ADC Drugs Production Mode & Process
12.4 Monoclonal Antibody ADC Drugs Sales and Marketing
12.4.1 Monoclonal Antibody ADC Drugs Sales Channels
12.4.2 Monoclonal Antibody ADC Drugs Distributors
12.5 Monoclonal Antibody ADC Drugs Customers
13 Market Dynamics
13.1 Monoclonal Antibody ADC Drugs Industry Trends
13.2 Monoclonal Antibody ADC Drugs Market Drivers
13.3 Monoclonal Antibody ADC Drugs Market Challenges
13.4 Monoclonal Antibody ADC Drugs Market Restraints
14 Key Findings in The Global Monoclonal Antibody ADC Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Monoclonal Antibody ADC Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of CD30 Target Antigen
Table 3. Major Manufacturers of HER2 Target Antigen
Table 4. Major Manufacturers of CD22 Target Antigen
Table 5. Major Manufacturers of CD33 Target Antigen
Table 6. Major Manufacturers of Nectin-4 Target Antigen
Table 7. Major Manufacturers of Others
Table 8. Global Monoclonal Antibody ADC Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Monoclonal Antibody ADC Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Monoclonal Antibody ADC Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 11. Global Monoclonal Antibody ADC Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 12. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Region (2018-2024)
Table 13. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Region (2024-2029)
Table 14. Global Monoclonal Antibody ADC Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 15. Global Monoclonal Antibody ADC Drugs Sales by Region (2018-2024) & (K Units)
Table 16. Global Monoclonal Antibody ADC Drugs Sales by Region (2024-2029) & (K Units)
Table 17. Global Monoclonal Antibody ADC Drugs Sales Market Share by Region (2018-2024)
Table 18. Global Monoclonal Antibody ADC Drugs Sales Market Share by Region (2024-2029)
Table 19. Global Monoclonal Antibody ADC Drugs Sales by Manufacturers (2018-2024) & (K Units)
Table 20. Global Monoclonal Antibody ADC Drugs Sales Share by Manufacturers (2018-2024)
Table 21. Global Monoclonal Antibody ADC Drugs Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 22. Global Monoclonal Antibody ADC Drugs Revenue Share by Manufacturers (2018-2024)
Table 23. Global Key Players of Monoclonal Antibody ADC Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 24. Monoclonal Antibody ADC Drugs Price by Manufacturers 2018-2024 (US$/Unit)
Table 25. Global Monoclonal Antibody ADC Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Monoclonal Antibody ADC Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody ADC Drugs as of 2022)
Table 27. Global Key Manufacturers of Monoclonal Antibody ADC Drugs, Manufacturing Base Distribution and Headquarters
Table 28. Global Key Manufacturers of Monoclonal Antibody ADC Drugs, Product Offered and Application
Table 29. Global Key Manufacturers of Monoclonal Antibody ADC Drugs, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Monoclonal Antibody ADC Drugs Sales by Type (2018-2024) & (K Units)
Table 32. Global Monoclonal Antibody ADC Drugs Sales by Type (2024-2029) & (K Units)
Table 33. Global Monoclonal Antibody ADC Drugs Sales Share by Type (2018-2024)
Table 34. Global Monoclonal Antibody ADC Drugs Sales Share by Type (2024-2029)
Table 35. Global Monoclonal Antibody ADC Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 36. Global Monoclonal Antibody ADC Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 37. Global Monoclonal Antibody ADC Drugs Revenue Share by Type (2018-2024)
Table 38. Global Monoclonal Antibody ADC Drugs Revenue Share by Type (2024-2029)
Table 39. Monoclonal Antibody ADC Drugs Price by Type (2018-2024) & (US$/Unit)
Table 40. Global Monoclonal Antibody ADC Drugs Price Forecast by Type (2024-2029) & (US$/Unit)
Table 41. Global Monoclonal Antibody ADC Drugs Sales by Application (2018-2024) & (K Units)
Table 42. Global Monoclonal Antibody ADC Drugs Sales by Application (2024-2029) & (K Units)
Table 43. Global Monoclonal Antibody ADC Drugs Sales Share by Application (2018-2024)
Table 44. Global Monoclonal Antibody ADC Drugs Sales Share by Application (2024-2029)
Table 45. Global Monoclonal Antibody ADC Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 46. Global Monoclonal Antibody ADC Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 47. Global Monoclonal Antibody ADC Drugs Revenue Share by Application (2018-2024)
Table 48. Global Monoclonal Antibody ADC Drugs Revenue Share by Application (2024-2029)
Table 49. Monoclonal Antibody ADC Drugs Price by Application (2018-2024) & (US$/Unit)
Table 50. Global Monoclonal Antibody ADC Drugs Price Forecast by Application (2024-2029) & (US$/Unit)
Table 51. US & Canada Monoclonal Antibody ADC Drugs Sales by Type (2018-2024) & (K Units)
Table 52. US & Canada Monoclonal Antibody ADC Drugs Sales by Type (2024-2029) & (K Units)
Table 53. US & Canada Monoclonal Antibody ADC Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 54. US & Canada Monoclonal Antibody ADC Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 55. US & Canada Monoclonal Antibody ADC Drugs Sales by Application (2018-2024) & (K Units)
Table 56. US & Canada Monoclonal Antibody ADC Drugs Sales by Application (2024-2029) & (K Units)
Table 57. US & Canada Monoclonal Antibody ADC Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 58. US & Canada Monoclonal Antibody ADC Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 59. US & Canada Monoclonal Antibody ADC Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 60. US & Canada Monoclonal Antibody ADC Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 61. US & Canada Monoclonal Antibody ADC Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 62. US & Canada Monoclonal Antibody ADC Drugs Sales by Country (2018-2024) & (K Units)
Table 63. US & Canada Monoclonal Antibody ADC Drugs Sales by Country (2024-2029) & (K Units)
Table 64. Europe Monoclonal Antibody ADC Drugs Sales by Type (2018-2024) & (K Units)
Table 65. Europe Monoclonal Antibody ADC Drugs Sales by Type (2024-2029) & (K Units)
Table 66. Europe Monoclonal Antibody ADC Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe Monoclonal Antibody ADC Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 68. Europe Monoclonal Antibody ADC Drugs Sales by Application (2018-2024) & (K Units)
Table 69. Europe Monoclonal Antibody ADC Drugs Sales by Application (2024-2029) & (K Units)
Table 70. Europe Monoclonal Antibody ADC Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 71. Europe Monoclonal Antibody ADC Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 72. Europe Monoclonal Antibody ADC Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 73. Europe Monoclonal Antibody ADC Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe Monoclonal Antibody ADC Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 75. Europe Monoclonal Antibody ADC Drugs Sales by Country (2018-2024) & (K Units)
Table 76. Europe Monoclonal Antibody ADC Drugs Sales by Country (2024-2029) & (K Units)
Table 77. China Monoclonal Antibody ADC Drugs Sales by Type (2018-2024) & (K Units)
Table 78. China Monoclonal Antibody ADC Drugs Sales by Type (2024-2029) & (K Units)
Table 79. China Monoclonal Antibody ADC Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 80. China Monoclonal Antibody ADC Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 81. China Monoclonal Antibody ADC Drugs Sales by Application (2018-2024) & (K Units)
Table 82. China Monoclonal Antibody ADC Drugs Sales by Application (2024-2029) & (K Units)
Table 83. China Monoclonal Antibody ADC Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 84. China Monoclonal Antibody ADC Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 85. Asia Monoclonal Antibody ADC Drugs Sales by Type (2018-2024) & (K Units)
Table 86. Asia Monoclonal Antibody ADC Drugs Sales by Type (2024-2029) & (K Units)
Table 87. Asia Monoclonal Antibody ADC Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 88. Asia Monoclonal Antibody ADC Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 89. Asia Monoclonal Antibody ADC Drugs Sales by Application (2018-2024) & (K Units)
Table 90. Asia Monoclonal Antibody ADC Drugs Sales by Application (2024-2029) & (K Units)
Table 91. Asia Monoclonal Antibody ADC Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 92. Asia Monoclonal Antibody ADC Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 93. Asia Monoclonal Antibody ADC Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 94. Asia Monoclonal Antibody ADC Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 95. Asia Monoclonal Antibody ADC Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 96. Asia Monoclonal Antibody ADC Drugs Sales by Region (2018-2024) & (K Units)
Table 97. Asia Monoclonal Antibody ADC Drugs Sales by Region (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Sales by Type (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Sales by Type (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Sales by Application (2018-2024) & (K Units)
Table 103. Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Sales by Application (2024-2029) & (K Units)
Table 104. Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 107. Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 108. Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 109. Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Sales by Country (2018-2024) & (K Units)
Table 110. Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Sales by Country (2024-2029) & (K Units)
Table 111. Seattle Company Information
Table 112. Seattle Description and Major Businesses
Table 113. Seattle Monoclonal Antibody ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 114. Seattle Monoclonal Antibody ADC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Seattle Recent Developments
Table 116. Roche Company Information
Table 117. Roche Description and Major Businesses
Table 118. Roche Monoclonal Antibody ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 119. Roche Monoclonal Antibody ADC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Roche Recent Developments
Table 121. Pfizer Company Information
Table 122. Pfizer Description and Major Businesses
Table 123. Pfizer Monoclonal Antibody ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 124. Pfizer Monoclonal Antibody ADC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Pfizer Recent Developments
Table 126. AstraZeneca Company Information
Table 127. AstraZeneca Description and Major Businesses
Table 128. AstraZeneca Monoclonal Antibody ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 129. AstraZeneca Monoclonal Antibody ADC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. AstraZeneca Recent Developments
Table 131. Immunomedics Company Information
Table 132. Immunomedics Description and Major Businesses
Table 133. Immunomedics Monoclonal Antibody ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 134. Immunomedics Monoclonal Antibody ADC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Immunomedics Recent Developments
Table 136. GSK Company Information
Table 137. GSK Description and Major Businesses
Table 138. GSK Monoclonal Antibody ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 139. GSK Monoclonal Antibody ADC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. GSK Recent Developments
Table 141. ADC Therapeutics Company Information
Table 142. ADC Therapeutics Description and Major Businesses
Table 143. ADC Therapeutics Monoclonal Antibody ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 144. ADC Therapeutics Monoclonal Antibody ADC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. ADC Therapeutics Recent Developments
Table 146. Lepu Biopharma Company Information
Table 147. Lepu Biopharma Description and Major Businesses
Table 148. Lepu Biopharma Monoclonal Antibody ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 149. Lepu Biopharma Monoclonal Antibody ADC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Lepu Biopharma Recent Developments
Table 151. Shanghai Junshi Biosciences Company Information
Table 152. Shanghai Junshi Biosciences Description and Major Businesses
Table 153. Shanghai Junshi Biosciences Monoclonal Antibody ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 154. Shanghai Junshi Biosciences Monoclonal Antibody ADC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Shanghai Junshi Biosciences Recent Developments
Table 156. RemeGen Company Information
Table 157. RemeGen Description and Major Businesses
Table 158. RemeGen Monoclonal Antibody ADC Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 159. RemeGen Monoclonal Antibody ADC Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. RemeGen Recent Developments
Table 161. Key Raw Materials Lists
Table 162. Raw Materials Key Suppliers Lists
Table 163. Monoclonal Antibody ADC Drugs Distributors List
Table 164. Monoclonal Antibody ADC Drugs Customers List
Table 165. Monoclonal Antibody ADC Drugs Market Trends
Table 166. Monoclonal Antibody ADC Drugs Market Drivers
Table 167. Monoclonal Antibody ADC Drugs Market Challenges
Table 168. Monoclonal Antibody ADC Drugs Market Restraints
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Monoclonal Antibody ADC Drugs Product Picture
Figure 2. Global Monoclonal Antibody ADC Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Monoclonal Antibody ADC Drugs Market Share by Type in 2022 & 2029
Figure 4. CD30 Target Antigen Product Picture
Figure 5. HER2 Target Antigen Product Picture
Figure 6. CD22 Target Antigen Product Picture
Figure 7. CD33 Target Antigen Product Picture
Figure 8. Nectin-4 Target Antigen Product Picture
Figure 9. Others Product Picture
Figure 10. Global Monoclonal Antibody ADC Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 11. Global Monoclonal Antibody ADC Drugs Market Share by Application in 2022 & 2029
Figure 12. Lymphoma
Figure 13. Breast Cancer
Figure 14. Leukemia
Figure 15. Myeloma
Figure 16. Others
Figure 17. Monoclonal Antibody ADC Drugs Report Years Considered
Figure 18. Global Monoclonal Antibody ADC Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global Monoclonal Antibody ADC Drugs Revenue 2018-2029 (US$ Million)
Figure 20. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 21. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Region (2018-2029)
Figure 22. Global Monoclonal Antibody ADC Drugs Sales 2018-2029 ((K Units)
Figure 23. Global Monoclonal Antibody ADC Drugs Sales Market Share by Region (2018-2029)
Figure 24. US & Canada Monoclonal Antibody ADC Drugs Sales YoY (2018-2029) & (K Units)
Figure 25. US & Canada Monoclonal Antibody ADC Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Europe Monoclonal Antibody ADC Drugs Sales YoY (2018-2029) & (K Units)
Figure 27. Europe Monoclonal Antibody ADC Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 28. China Monoclonal Antibody ADC Drugs Sales YoY (2018-2029) & (K Units)
Figure 29. China Monoclonal Antibody ADC Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 30. Asia (excluding China) Monoclonal Antibody ADC Drugs Sales YoY (2018-2029) & (K Units)
Figure 31. Asia (excluding China) Monoclonal Antibody ADC Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 32. Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Sales YoY (2018-2029) & (K Units)
Figure 33. Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 34. The Monoclonal Antibody ADC Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 35. The Top 5 and 10 Largest Manufacturers of Monoclonal Antibody ADC Drugs in the World: Market Share by Monoclonal Antibody ADC Drugs Revenue in 2022
Figure 36. Global Monoclonal Antibody ADC Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 37. Global Monoclonal Antibody ADC Drugs Sales Market Share by Type (2018-2029)
Figure 38. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Type (2018-2029)
Figure 39. Global Monoclonal Antibody ADC Drugs Sales Market Share by Application (2018-2029)
Figure 40. Global Monoclonal Antibody ADC Drugs Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Monoclonal Antibody ADC Drugs Sales Market Share by Type (2018-2029)
Figure 42. US & Canada Monoclonal Antibody ADC Drugs Revenue Market Share by Type (2018-2029)
Figure 43. US & Canada Monoclonal Antibody ADC Drugs Sales Market Share by Application (2018-2029)
Figure 44. US & Canada Monoclonal Antibody ADC Drugs Revenue Market Share by Application (2018-2029)
Figure 45. US & Canada Monoclonal Antibody ADC Drugs Revenue Share by Country (2018-2029)
Figure 46. US & Canada Monoclonal Antibody ADC Drugs Sales Share by Country (2018-2029)
Figure 47. U.S. Monoclonal Antibody ADC Drugs Revenue (2018-2029) & (US$ Million)
Figure 48. Canada Monoclonal Antibody ADC Drugs Revenue (2018-2029) & (US$ Million)
Figure 49. Europe Monoclonal Antibody ADC Drugs Sales Market Share by Type (2018-2029)
Figure 50. Europe Monoclonal Antibody ADC Drugs Revenue Market Share by Type (2018-2029)
Figure 51. Europe Monoclonal Antibody ADC Drugs Sales Market Share by Application (2018-2029)
Figure 52. Europe Monoclonal Antibody ADC Drugs Revenue Market Share by Application (2018-2029)
Figure 53. Europe Monoclonal Antibody ADC Drugs Revenue Share by Country (2018-2029)
Figure 54. Europe Monoclonal Antibody ADC Drugs Sales Share by Country (2018-2029)
Figure 55. Germany Monoclonal Antibody ADC Drugs Revenue (2018-2029) & (US$ Million)
Figure 56. France Monoclonal Antibody ADC Drugs Revenue (2018-2029) & (US$ Million)
Figure 57. U.K. Monoclonal Antibody ADC Drugs Revenue (2018-2029) & (US$ Million)
Figure 58. Italy Monoclonal Antibody ADC Drugs Revenue (2018-2029) & (US$ Million)
Figure 59. Russia Monoclonal Antibody ADC Drugs Revenue (2018-2029) & (US$ Million)
Figure 60. China Monoclonal Antibody ADC Drugs Sales Market Share by Type (2018-2029)
Figure 61. China Monoclonal Antibody ADC Drugs Revenue Market Share by Type (2018-2029)
Figure 62. China Monoclonal Antibody ADC Drugs Sales Market Share by Application (2018-2029)
Figure 63. China Monoclonal Antibody ADC Drugs Revenue Market Share by Application (2018-2029)
Figure 64. Asia Monoclonal Antibody ADC Drugs Sales Market Share by Type (2018-2029)
Figure 65. Asia Monoclonal Antibody ADC Drugs Revenue Market Share by Type (2018-2029)
Figure 66. Asia Monoclonal Antibody ADC Drugs Sales Market Share by Application (2018-2029)
Figure 67. Asia Monoclonal Antibody ADC Drugs Revenue Market Share by Application (2018-2029)
Figure 68. Asia Monoclonal Antibody ADC Drugs Revenue Share by Region (2018-2029)
Figure 69. Asia Monoclonal Antibody ADC Drugs Sales Share by Region (2018-2029)
Figure 70. Japan Monoclonal Antibody ADC Drugs Revenue (2018-2029) & (US$ Million)
Figure 71. South Korea Monoclonal Antibody ADC Drugs Revenue (2018-2029) & (US$ Million)
Figure 72. China Taiwan Monoclonal Antibody ADC Drugs Revenue (2018-2029) & (US$ Million)
Figure 73. Southeast Asia Monoclonal Antibody ADC Drugs Revenue (2018-2029) & (US$ Million)
Figure 74. India Monoclonal Antibody ADC Drugs Revenue (2018-2029) & (US$ Million)
Figure 75. Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Sales Market Share by Type (2018-2029)
Figure 76. Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Revenue Market Share by Type (2018-2029)
Figure 77. Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Sales Market Share by Application (2018-2029)
Figure 78. Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Revenue Market Share by Application (2018-2029)
Figure 79. Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Revenue Share by Country (2018-2029)
Figure 80. Middle East, Africa and Latin America Monoclonal Antibody ADC Drugs Sales Share by Country (2018-2029)
Figure 81. Brazil Monoclonal Antibody ADC Drugs Revenue (2018-2029) & (US$ Million)
Figure 82. Mexico Monoclonal Antibody ADC Drugs Revenue (2018-2029) & (US$ Million)
Figure 83. Turkey Monoclonal Antibody ADC Drugs Revenue (2018-2029) & (US$ Million)
Figure 84. Israel Monoclonal Antibody ADC Drugs Revenue (2018-2029) & (US$ Million)
Figure 85. GCC Countries Monoclonal Antibody ADC Drugs Revenue (2018-2029) & (US$ Million)
Figure 86. Monoclonal Antibody ADC Drugs Value Chain
Figure 87. Monoclonal Antibody ADC Drugs Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries